Amazon.com has announced that it is acquiring PillPack. The terms of the deal were undisclosed, but there are rumors that it was for $1 billion in cash.
Tricida, a biopharmaceutical company focused on developing chronic therapies addressing renal disease complications, has raised $30 million in Series B funding.
Tempered Networks is a company that provides secure connectivity for critical infrastructure customers that has raised $15 million in Series A funding.